![Carl Adams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl Adams
Comptroller/Controller/Auditor bei TELEDYNE TECHNOLOGIES INCORPORATED
Aktive Positionen von Carl Adams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TELEDYNE TECHNOLOGIES INCORPORATED | Comptroller/Controller/Auditor | 01.12.2023 | - |
Karriereverlauf von Carl Adams
Ehemalige bekannte Positionen von Carl Adams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NeuroSigma, Inc.
![]() NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Comptroller/Controller/Auditor | 11.02.2014 | - |
Finanzdirektor/CFO | 11.02.2014 | - |
Ausbildung von Carl Adams
California State University-Northridge | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TELEDYNE TECHNOLOGIES INCORPORATED | Electronic Technology |
Private Unternehmen | 1 |
---|---|
NeuroSigma, Inc.
![]() NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |
- Börse
- Insiders
- Carl Adams
- Erfahrung